Instil Bio Financials

TIL Stock  USD 7.99  0.21  2.70%   
Based on the analysis of Instil Bio's profitability, liquidity, and operating efficiency, Instil Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At this time, Instil Bio's Liabilities And Stockholders Equity is quite stable compared to the past year. Total Current Assets is expected to rise to about 233.6 M this year, although the value of Total Current Liabilities will most likely fall to about 8.6 M.
 
Covid
 
Interest Hikes

Instil Bio Balance Sheet Chart

At this time, Instil Bio's Liabilities And Stockholders Equity is quite stable compared to the past year. Total Current Assets is expected to rise to about 233.6 M this year, although the value of Total Current Liabilities will most likely fall to about 8.6 M.
Key indicators impacting Instil Bio's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.30.46
Way Down
Slightly volatile
Current Ratio10.0614.19
Way Down
Slightly volatile
The essential information of the day-to-day investment outlook for Instil Bio includes many different criteria found on its balance sheet. An individual investor should research Instil Bio's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Instil Bio.

Net Income

(70.06 Million)

  
Build AI portfolio with Instil Stock

Instil Bio Earnings Geography

Instil Bio Stock Summary

Instil Bio competes with Zentalis Pharmaceuticals, Surrozen, Pliant Therapeutics, Oncolytics Biotech, and Atossa Genetics. Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45783C2008
Business Address3963 Maple Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteinstilbio.com
Phone972 499 3350
CurrencyUSD - US Dollar

Instil Bio Key Financial Ratios

Instil Bio Key Balance Sheet Accounts

202120222023202420252026 (projected)
Total Assets610.0M482.1M325.6M263.6M303.1M368.5M
Other Current Liab35.3M28.0M7.6M5.6M6.4M6.1M
Net Debt(37.6M)36.2M76.9M78.1M89.8M94.3M
Retained Earnings(201.7M)(424.9M)(581.0M)(655.1M)(589.6M)(560.1M)
Accounts Payable5.6M2.4M1.2M659K593.1K563.4K
Cash37.6M43.7M9.2M8.8M7.9M7.5M
Other Current Assets9.9M8.5M10.4M11.2M12.8M8.2M
Total Liab54.8M118.5M99.8M94.1M108.3M72.5M
Net Invested Capital555.2M436.0M307.3M253.6M291.7M276.0M
Total Current Assets464.0M269.4M160.8M124.5M143.1M233.6M
Net Working Capital422.7M236.6M150.2M116.6M134.1M213.9M

Instil Bio Key Income Statement Accounts

202120222023202420252026 (projected)
Tax Provision151K39K(2.1M)(605K)(544.5K)(571.7K)
Net Interest Income3.8M1.8M4.5M(2.0M)(2.3M)(2.2M)
Interest Income80K3.7M8.5M7.0M8.0M8.4M
Interest Expense1.6M1.9M5.2M9.0M10.3M10.9M
Gross Profit(2.8M)(6.0M)(4.8M)(3.6M)(3.2M)(3.4M)
Operating Income(155.6M)(206.2M)(159.2M)(73.5M)(66.2M)(69.5M)
Ebit(155.6M)(223.4M)(151.9M)(66.1M)(59.5M)(62.5M)
Research Development107.3M141.1M39.6M11.8M13.6M12.9M
Ebitda(152.8M)(217.4M)(147.1M)(62.5M)(56.3M)(59.1M)
Income Before Tax(156.8M)(225.3M)(156.1M)(74.1M)(66.7M)(70.1M)
Net Income(156.8M)(223.2M)(156.1M)(74.1M)(66.7M)(70.1M)

Instil Bio Key Cash Accounts

202120222023202420252026 (projected)
Investments(416.6M)114.5M60.0M54.0M62.1M65.2M
Change In Cash(203.7M)5.6M(33.0M)(61K)(54.9K)(52.2K)
Free Cash Flow(180.0M)(264.8M)(102.7M)(65.7M)(59.1M)(62.1M)
Depreciation2.8M6.0M4.8M3.6M4.2M3.2M
Other Non Cash Items636K16.2M60.2M10.2M11.7M16.9M
Capital Expenditures57.8M84.6M20.7M10M9M8.6M
Net Income(156.8M)(223.2M)(156.1M)(74.1M)(66.7M)(70.1M)
End Period Cash Flow38.1M43.7M10.7M10.6M9.6M9.1M

Instil Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Instil Bio's current stock value. Our valuation model uses many indicators to compare Instil Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Instil Bio competition to find correlations between indicators driving Instil Bio's intrinsic value. More Info.
Instil Bio is rated fourth in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers . At this time, Instil Bio's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Instil Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Instil Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Instil Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.The value of Tax Provision is estimated to slide to about (571.7 K). The value of Selling General Administrative is expected to slide to about 40.2 M
 2023 2024 2025 2026 (projected)
Depreciation And Amortization4.8M3.6M4.2M3.2M
Interest Income8.5M7.0M8.0M8.4M

Instil Bio fundamental ratios Correlations

0.890.90.990.830.90.09-0.690.660.330.920.97-0.150.860.830.810.910.890.970.970.90.340.630.570.46-0.32
0.891.00.920.610.72-0.05-0.370.830.270.730.92-0.460.610.630.590.850.710.920.910.640.040.40.740.630.0
0.91.00.930.620.73-0.05-0.390.830.280.750.93-0.450.640.650.60.860.730.930.920.660.060.410.730.63-0.02
0.990.920.930.750.82-0.02-0.580.760.380.841.0-0.270.780.740.710.870.811.01.00.830.270.590.650.57-0.28
0.830.610.620.750.930.61-0.940.18-0.140.930.690.210.950.970.930.920.930.710.710.970.590.790.310.18-0.55
0.90.720.730.820.930.4-0.890.30.111.00.760.180.940.950.980.91.00.770.770.950.460.630.240.08-0.37
0.09-0.05-0.05-0.020.610.4-0.63-0.53-0.830.37-0.090.410.410.560.490.430.41-0.07-0.080.420.460.45-0.13-0.21-0.43
-0.69-0.37-0.39-0.58-0.94-0.89-0.630.060.1-0.89-0.5-0.42-0.93-0.93-0.94-0.75-0.89-0.52-0.52-0.93-0.59-0.72-0.020.120.53
0.660.830.830.760.180.3-0.530.060.550.350.81-0.720.280.220.150.490.290.790.790.29-0.220.120.830.790.24
0.330.270.280.38-0.140.11-0.830.10.550.150.42-0.120.09-0.090.04-0.080.10.410.420.1-0.12-0.10.050.060.12
0.920.730.750.840.931.00.37-0.890.350.150.790.150.950.950.980.911.00.80.80.970.460.640.280.12-0.37
0.970.920.931.00.690.76-0.09-0.50.810.420.79-0.330.730.680.640.840.741.01.00.780.230.560.70.63-0.26
-0.15-0.46-0.45-0.270.210.180.41-0.42-0.72-0.120.15-0.330.210.190.31-0.140.19-0.32-0.310.210.720.25-0.73-0.78-0.56
0.860.610.640.780.950.940.41-0.930.280.090.950.730.210.980.950.870.930.750.750.970.560.750.310.15-0.42
0.830.630.650.740.970.950.56-0.930.22-0.090.950.680.190.980.960.920.950.70.70.950.530.730.310.14-0.39
0.810.590.60.710.930.980.49-0.940.150.040.980.640.310.950.960.840.980.660.650.950.520.630.11-0.06-0.39
0.910.850.860.870.920.90.43-0.750.49-0.080.910.84-0.140.870.920.840.90.850.840.890.360.670.590.45-0.3
0.890.710.730.810.931.00.41-0.890.290.11.00.740.190.930.950.980.90.760.750.950.460.630.220.06-0.37
0.970.920.931.00.710.77-0.07-0.520.790.410.81.0-0.320.750.70.660.850.761.00.80.240.580.690.62-0.27
0.970.910.921.00.710.77-0.08-0.520.790.420.81.0-0.310.750.70.650.840.751.00.80.250.580.690.62-0.27
0.90.640.660.830.970.950.42-0.930.290.10.970.780.210.970.950.950.890.950.80.80.590.780.30.17-0.54
0.340.040.060.270.590.460.46-0.59-0.22-0.120.460.230.720.560.530.520.360.460.240.250.590.74-0.07-0.12-0.85
0.630.40.410.590.790.630.45-0.720.12-0.10.640.560.250.750.730.630.670.630.580.580.780.740.350.29-0.71
0.570.740.730.650.310.24-0.13-0.020.830.050.280.7-0.730.310.310.110.590.220.690.690.3-0.070.350.970.09
0.460.630.630.570.180.08-0.210.120.790.060.120.63-0.780.150.14-0.060.450.060.620.620.17-0.120.290.970.02
-0.320.0-0.02-0.28-0.55-0.37-0.430.530.240.12-0.37-0.26-0.56-0.42-0.39-0.39-0.3-0.37-0.27-0.27-0.54-0.85-0.710.090.02
Click cells to compare fundamentals

Instil Bio Account Relationship Matchups

Instil Bio fundamental ratios Accounts

202120222023202420252026 (projected)
Total Assets610.0M482.1M325.6M263.6M303.1M368.5M
Other Current Liab35.3M28.0M7.6M5.6M6.4M6.1M
Net Debt(37.6M)36.2M76.9M78.1M89.8M94.3M
Retained Earnings(201.7M)(424.9M)(581.0M)(655.1M)(589.6M)(560.1M)
Accounts Payable5.6M2.4M1.2M659K593.1K563.4K
Cash37.6M43.7M9.2M8.8M7.9M7.5M
Other Current Assets9.9M8.5M10.4M11.2M12.8M8.2M
Total Liab54.8M118.5M99.8M94.1M108.3M72.5M
Net Invested Capital555.2M436.0M307.3M253.6M291.7M276.0M
Total Current Assets464.0M269.4M160.8M124.5M143.1M233.6M
Net Working Capital422.7M236.6M150.2M116.6M134.1M213.9M
Today, most investors in Instil Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Instil Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Instil Bio growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0302

At this time, Instil Bio's Price Earnings To Growth Ratio is quite stable compared to the past year.

Instil Bio February 15, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Instil Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Instil Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Instil Bio based on widely used predictive technical indicators. In general, we focus on analyzing Instil Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Instil Bio's daily price indicators and compare them against related drivers.
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Instil Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(11.35)
Return On Assets
(0.15)
Return On Equity
(0.51)
Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.